Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
18.52
-0.52 (-2.73%)
At close: Oct 16, 2026, 4:00 PM EDT
18.90
+0.38 (2.05%)
Pre-market: Oct 19, 2026, 8:36 AM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.27 billion as of October 16, 2026. It is the 8,830th most valuable company in the world and the 2,066th biggest in the United States. Its market cap has increased by 56.15% in one year.
Market Cap
1.27B
Enterprise Value
925.00M
1-Year Change
56.15%
Global Rank
Country Rank
#2,066 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.27B, an increase of 94.51%. That is a compound annual growth rate of 13.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.27B | -9.25% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.39B |
| Rapport Therapeutics | 1.32B |
| Inhibrx Biosciences | 1.32B |
| ORIC Pharmaceuticals | 1.28B |
| GH Research | 1.25B |
| First Tracks Biotherapeutics | 1.23B |
| Nektar Therapeutics | 1.22B |
| Kardigan | 1.22B |